August 02, 2022
Oxford, UK and Cleveland, Ohio, USA – The Oxford-Harrington Rare Disease Centre (OHC), a partnership of the University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced its support of a novel treatment for Duchenne muscular dystrophy, a rare neuromuscular disease...
Continue ReadingJanuary 08, 2016
Cleveland– January 8, 2016 – Dual Therapeutics, LLC (“Dual Therapeutics”) today announced a strategic collaboration with Bristol-Myers Squibb (NYSE: BMY) to advance small molecule compounds for the treatment of cancer and other diseases. Dual Therapeutics’ small-molecule modulators simultaneously block multiple cancer... Continue Reading
May 01, 2015
- 2015 Harrington Scholar-Innovator Continue Reading
May 01, 2015
- 2015 Harrington Scholar-Innovator Continue Reading
May 01, 2015
- 2015 Oxford-Harrington Scholar Continue Reading
May 01, 2015
- 2015 ADDF-Harrington Scholar Continue Reading
January 01, 2015
Momentum: Moving Medicine Forward Continue Reading
May 01, 2014
- 2014 Harrington Scholar-Innovator Continue Reading
January 01, 2012
Celebrating a Year of Accomplishments Continue Reading